Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new drug that fights aggressive breast cancers. Tucatinib is a daily… Read More
Seattle-based nonprofit Sage Bionetworks is leading a heavily funded national effort to find new drugs to fight Alzheimer’s, a disease that has stymied the efforts of big pharma for decades.… Read More
Microsoft has reached a deal with pharmaceutical giant Novartis that aims to bring the power of artificial intelligence to drug discovery. “AI is perhaps the most transformational technology of our… Read More
Sound Pharmaceuticals, a Seattle-based drugmaker that is creating a first-of-its-kind treatment for hearing loss, recently reported encouraging top-line results from a Phase II clinical trial and is eyeing a potential… Read More
Seattle Genetics on Thursday reported higher-than-expected losses for the fourth quarter, sending shares down 8 percent in after-hours trading. Quarterly revenues came in at $175 million, above Wall Street expectations… Read More